|
|
 |
 |
Possible inhibitors against X-DR TB discovered
CSIR researchers have made a breakthrough in isolating five compounds that show efficacy against X-DR TB, the virulent strain of tuberculosis that has gripped the world. X-DR (extensively drug-resistant tuberculosis, those strains of TB resistant to both first and second line drugs), leaves infected people virtually untreatable with currently available anti-TB drugs. |
 |
New expertise to enhance CSIR drug development
The CSIR's efforts to establish a pre-clinical drug development platform for South Africa is set to receive a major boost with the appointment of Dr Paolo Meoni, a former drug development expert at Ablynx in Europe. |
 |
CSIR technology used for speeding up abalone growth
The fermentation skills of CSIR Biosciences have been used in a project aimed at shortening the growth period of abalone. The project stems from collaboration with the University of Cape Town (UCT) and aims to develop a probiotic for inclusion in abalone feed products. |
 |
Algal biodiesel - a worthy successor of fossil fuels?
Could harvesting biodiesel from algae provide a sustainable solution to the world's fuel crises? Researchers in the CSIR's bioprocessing development research group have embarked on a project to answer this question and present algae as an alternative energy source for Africa. |
|
|
